Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionEventide Asset Management, Llc
Latest Disclosed Ownership1,713 shares
Ownership 0.00%
Eventide Asset Management, Llc ownership in 9EH / Evolent Health, Inc.

2026-02-13 - Eventide Asset Management, Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,713 shares of Evolent Health, Inc. (DE:9EH). This represents 0.0 percent ownership of the company. In their previous filing dated 2025-11-14 , Eventide Asset Management, Llc had reported owning 6,292,511 shares, indicating a decrease of -99.97 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-02-13 2026-02-13 13G/A 6,292,511 1,713 -99.97 0.00 -100.00
2025-11-14 2025-11-14 13G/A 4,086,852 6,292,511 53.97 5.40 54.29
2025-08-14 2025-08-14 13G/A 6,077,191 4,086,852 -32.75 3.50 -32.69
2025-05-14 2025-05-14 13G 6,077,191 5.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 2,547,558 2,547,558 5,808 0.0961
2026-02-13 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 0 -6,292,511 -100.00 0 -100.00
2025-11-14 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 6,292,511 2,205,659 53.97 53,246 15.71 0.8754
2025-08-14 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 4,086,852 -1,990,339 -32.75 46,014 -20.05 0.8062
2025-05-15 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 6,077,191 1,524,885 33.50 57,555 12.39 1.1465
2025-02-14 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 4,552,306 748,202 19.67 51,208 -52.40 0.9325
2024-11-14 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 3,804,104 64,985 1.74 107,580 50.48 1.8542
2024-08-13 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 3,739,119 1,096,551 41.50 71,492 -17.49 1.2238
2024-05-15 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 2,642,568 3,622 0.14 86,650 -0.59 1.3588
2024-02-20 2023-12-31 13F/A-1 EVOLENT HEALTH CL A 30050B101 2,638,946 6 0.00 87,164 21.30 1.4227
2024-02-14 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 2,638,946 6 87,164 1.4225
2023-11-14 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 2,638,940 796 0.03 71,858 -10.10 1.2915
2023-08-15 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 2,638,144 735,389 38.65 79,936 29.46 1.3510
2023-05-15 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 1,902,755 0 0.00 61,744 15.56 1.1328
2023-02-13 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 1,902,755 1,686,055 778.06 53,429 586.22 1.0536
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 216,700 0 0.00 7,786 16.99 0.1532
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 216,700 216,700 6,655 0.1423
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.